Hanmi to patent human growth hormone in liquid composite.

Hanmi has registered a patent for a stabilized liquid form of human growth hormone composite in Korea, which was developed by 2,850 million won of investment. The discovery showed not to use conventional preservatives and surfactants in liquid preparations but only to use PEG to improve the safety and stability of liquid form of human growth hormone.

Hanmi said that the biological half life ...